Global Gene Fusion Testing Market by Technique (Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Nanostring), Indication (Haematological Malignacies, Solid Tumors), Application, End User - Forecast 2024-2030- Product Image

Sale

Global Gene Fusion Testing Market by Technique (Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Nanostring), Indication (Haematological Malignacies, Solid Tumors), Application, End User - Forecast 2024-2030

Report
187 Pages
March 2024
Region: Global
360iResearch™
ID: 5924686

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Gene Fusion Testing Market size was estimated at USD 428.34 million in 2023, USD 480.95 million in 2024, and is expected to grow at a CAGR of 12.40% to reach USD 971.34 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Fusion Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Fusion Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Fusion Testing Market, highlighting leading vendors and their innovative profiles. These include Amoy Diagnostics Co., Ltd., Arima Genomics, Inc., Biocare Medical, LLC, Biocartis NV, Caris Life Sciences, Danaher Corporation, Empire Genomics, Inc., F. Hoffmann-La Roche Ltd., Guardant Health, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Myriad Genetics, Inc., Natera, Inc., NeoGenomics, Inc., OncoDNA SA, Paragon Genomics, Inc., QIAGEN N.V., Quest Diagnostics Incorporated., SOPHiA GENETICS SA, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Gene Fusion Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technique
- Fluorescence In Situ Hybridization (FISH)
- Immunohistochemistry (IHC)
- Nanostring
- NGS Amplicon
- Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Indication
- Haematological Malignacies
- Solid Tumors
Application
- Disease Diagnosis
- Research
End User
- Academic & Research Centers
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Gene Fusion Testing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Fusion Testing Market?
What are the technology trends and regulatory frameworks in the Gene Fusion Testing Market?
What is the market share of the leading vendors in the Gene Fusion Testing Market?
Which modes and strategic moves are suitable for entering the Gene Fusion Testing Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Gene Fusion Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cancer worldwide
5.1.1.2. Increasing genomic and molecular biology reserach
5.1.1.3. Extensive use for discovery of biomarkers
5.1.2. Restraints
5.1.2.1. High cost and limited accessibility to gene fusion testing
5.1.3. Opportunities
5.1.3.1. Advent of liquid-biopsy based gene fusion testing technologies
5.1.3.2. Inclination towards personalize medicine and targeted therapies
5.1.4. Challenges
5.1.4.1. Stringent regulations and dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Gene Fusion Testing Market, by Technique

6.1. Introduction
6.2. Fluorescence In Situ Hybridization (FISH)
6.3. Immunohistochemistry (IHC)
6.4. Nanostring
6.5. NGS Amplicon
6.6. Reverse Transcription Polymerase Chain Reaction (RT-PCR)

7. Gene Fusion Testing Market, by Indication

7.1. Introduction
7.2. Haematological Malignacies
7.3. Solid Tumors

8. Gene Fusion Testing Market, by Application

8.1. Introduction
8.2. Disease Diagnosis
8.3. Research

9. Gene Fusion Testing Market, by End User

9.1. Introduction
9.2. Academic & Research Centers
9.3. Hospitals & Diagnostic Laboratories
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Gene Fusion Testing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Gene Fusion Testing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Gene Fusion Testing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Amoy Diagnostics Co., Ltd.
14.1.2. Arima Genomics, Inc.
14.1.3. Biocare Medical, LLC
14.1.4. Biocartis NV
14.1.5. Caris Life Sciences
14.1.6. Danaher Corporation
14.1.7. Empire Genomics, Inc.
14.1.8. F. Hoffmann-La Roche Ltd.
14.1.9. Guardant Health, Inc.
14.1.10. Illumina, Inc.
14.1.11. Integrated DNA Technologies, Inc.
14.1.12. Myriad Genetics, Inc.
14.1.13. Natera, Inc.
14.1.14. NeoGenomics, Inc.
14.1.15. OncoDNA SA
14.1.16. Paragon Genomics, Inc.
14.1.17. QIAGEN N.V.
14.1.18. Quest Diagnostics Incorporated.
14.1.19. SOPHiA GENETICS SA
14.1.20. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GENE FUSION TESTING MARKET RESEARCH PROCESS
FIGURE 2. GENE FUSION TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GENE FUSION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GENE FUSION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GENE FUSION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENE FUSION TESTING MARKET DYNAMICS
FIGURE 7. GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 8. GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GENE FUSION TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. GENE FUSION TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GENE FUSION TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. GENE FUSION TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. GENE FUSION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GENE FUSION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 6. GENE FUSION TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION (FISH), BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GENE FUSION TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GENE FUSION TESTING MARKET SIZE, BY NANOSTRING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GENE FUSION TESTING MARKET SIZE, BY NGS AMPLICON, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GENE FUSION TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. GENE FUSION TESTING MARKET SIZE, BY HAEMATOLOGICAL MALIGNACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GENE FUSION TESTING MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. GENE FUSION TESTING MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GENE FUSION TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. GENE FUSION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GENE FUSION TESTING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. CANADA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 35. CANADA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. CANADA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. MEXICO GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. MEXICO GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. CHINA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 57. CHINA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CHINA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. INDIA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 61. INDIA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDIA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. JAPAN GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 69. JAPAN GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. JAPAN GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. THAILAND GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 93. THAILAND GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. THAILAND GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 106. DENMARK GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. DENMARK GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EGYPT GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. EGYPT GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. EGYPT GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. FINLAND GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 114. FINLAND GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FINLAND GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. FRANCE GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. GERMANY GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. ITALY GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 130. ITALY GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ITALY GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. NORWAY GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 142. NORWAY GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. NORWAY GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. POLAND GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 146. POLAND GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. POLAND GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. QATAR GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 150. QATAR GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. QATAR GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SPAIN GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. TURKEY GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. TURKEY GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. GENE FUSION TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. GENE FUSION TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. GENE FUSION TESTING MARKET LICENSE & PRICING

Companies Mentioned

Amoy Diagnostics Co., Ltd.
Arima Genomics, Inc.
Biocare Medical, LLC
Biocartis NV
Caris Life Sciences
Danaher Corporation
Empire Genomics, Inc.
F. Hoffmann-La Roche Ltd.
Guardant Health, Inc.
Illumina, Inc.
Integrated DNA Technologies, Inc.
Myriad Genetics, Inc.
Natera, Inc.
NeoGenomics, Inc.
OncoDNA SA
Paragon Genomics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated.
SOPHiA GENETICS SA
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	187
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 480.95 Million
Forecasted Market Value ( USD ) by 2030	$ 971.34 Million
Compound Annual Growth Rate	12.4%
Regions Covered	Global
No. of Companies Mentioned	20

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Gene Fusion Testing Market - A Global and Regional Analysis: Focus on by Category, Technology, Indication, End User, and Region - Analysis and Forecast, 2023-2033

Gene Fusion Testing Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test Type, By Stage Of Development, By Product Type, By Indication, By Region, And Segment Forecasts, 2023 - 2030

Global Gene Panel Market by Technique (Microarray, Next-Generation Sequencing, Polymerase Chain Reaction), Product (Test Kits, Testing Services), Application, End-User - Forecast 2024-2030

Global Lentiviral Vectors Market Report and Forecast 2024-2032